Post Hoc Subgroup Analysis

被引：0
|
作者：
Raschke, Robert A. [1 ]
机构：
[1] Banner Good Samaritan Med Ctr, Dept Med, Sect Crit Care, Phoenix, AZ 85006 USA
来源：
CHEST | 2014年 / 145卷 / 02期
关键词：
D O I：
10.1378/chest.13-2441
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [41] POST HOC ANALYSIS OF SUBSETS OF RESPONDERS
    READING, JC
    EGGER, MJ
    WARD, JR
    WILLIAMS, HJ
    COLEMAN, ML
    CONTROLLED CLINICAL TRIALS, 1982, 3 (02): : 143 - 143
  • [42] Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study
    Howard Jr, James F.
    Vu, Tuan
    Mantegazza, Renato
    Kushlaf, Hani
    Suzuki, Shigeaki
    Wiendl, Heinz
    Beasley, Kathleen N.
    Liao, Serena
    Meisel, Andreas
    MUSCLE & NERVE, 2024, 69 (05) : 556 - 565
  • [43] High Cleansing Efficacy of Ner1006 Also in the Elderly: Post Hoc Subgroup Analysis of Randomized Phase 3 Trials
    Jover, Rodrigo
    Shing, Richard Ng Kwet
    Uebel, Peter
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB195 - AB195
  • [44] Long-term Clinical Profile of Filgotinib in Patients with Rheumatoid Arthritis by Cardiovascular Risk Factors: A Post Hoc Subgroup Analysis
    Buch, Maya
    Gomez-Puerta, Jose A.
    Burmester, Gerd
    Combe, Bernard G.
    Rajendran, Vijay
    Stiers, Pieter-Jan
    Van Hoek, Paul
    Van Beneden, Katrien
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Aletaha, Daniel
    Westhovens, Rene
    Caporali, Roberto F.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 875 - 877
  • [45] Influence of Baseline Demographics on Improvements in Disease Activity Measures in Patients with Ankylosing Spondylitis Receiving Upadacitinib: A Post Hoc Subgroup Analysis
    Van den Bosch, Filip
    Poddubnyy, Denis
    Stigler, Jayne
    Ostor, Andrew
    D'Angelo, Salvatore
    Navarro-Compan, Victoria
    Song, In-Ho
    Gao, Tianming
    Ganz, Fabiana
    Gensler, Lianne
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1914 - 1916
  • [46] A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy
    Mackett, Katharine
    Dhesy-Thind, Sukhbinder
    Donovan, Elysia K.
    Mukherjee, Som
    Swaminath, Anand
    Leong, Darryl P.
    Voruganti, Sachi
    Sussman, Jonathan
    Wright, James
    Okawara, Gordon
    Fraser, Graham
    Sagar, Stephen
    Bordeleau, Louise
    Ellis, Peter M.
    Hirte, Hal
    Kavsak, Peter A.
    CLINICA CHIMICA ACTA, 2019, 495 : 355 - 357
  • [47] Impact of Concomitant Medication on Efficacy of Telotristat Ethyl - A Post Hoc Subgroup Analysis of the Phase 3 TELESTAR Study in Carcinoid Syndrome
    Anthony, L.
    Kulke, M. H.
    Hoersch, D.
    Bergsland, E.
    Oberg, K.
    Welin, S.
    Lombard-Bohas, C.
    Kunz, P.
    Valle, J. W.
    Kassler-Taub, K.
    Fleming, R.
    Pavel, M.
    NEUROENDOCRINOLOGY, 2017, 105 : 212 - 212
  • [48] SEMAGLUTIDE REDUCED CARDIOVASCULAR EVENTS REGARDLESS OF METFORMIN USE: A POST HOC EXPLORATORY SUBGROUP ANALYSIS OF SUSTAIN 6 AND PIONEER 6
    Husain, Mansoor
    Consoli, Agostino
    De Remigis, Alessandra
    Meyer, Anna Sina
    Rasmussen, Soren
    Bain, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1604 - 1604
  • [49] Post hoc power analysis: is it an informative and meaningful analysis?
    Zhang, Yiran
    Hedo, Rita
    Rivera, Anna
    Rull, Rudolph
    Richardson, Sabrina
    Tu, Xin M.
    GENERAL PSYCHIATRY, 2019, 32 (04)
  • [50] Melflufen: post-hoc subgroup analyses and the US FDA Oncologic Drugs Advisory Committee
    Cliff, Edward R. Scheffer
    Janakiram, Murali
    Kesselheim, Aaron S.
    LANCET HAEMATOLOGY, 2023, 10 (05): : E314 - E317
12345